Pharmaceutical compositions providing enhanced drug concentrations
US8202912B2 · kind B2 · utility
15Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2011 |
| Grant date | Jun 19, 2012 |
| Priority date | — |
| Expiry date | Aug 11, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.